ValGenesis, Inc., the global leader in digital validation lifecycle management, announced a strategic partnership with CAI, a professional services firm specializing in accelerating operational...
Quiver Bioscience, a discovery technology and therapeutics company advancing programs for treatment of serious central nervous system (CNS) disorders and chronic pain, announced receipt...
CIAI announced the launch of ciATHENA, a next generation Agentic AI platform built to accelerate commercial analytics across life sciences organizations. Combining natural language interfaces...
Powered by Causal AI and Real-Time Patient-Level Data and Analytics, the ClinOps Platform Enables Faster and Smarter Decision Making Across Trial Lifecycles
PhaseV, a leader...
Danaher Corporation, a leading global life sciences and diagnostics innovator, announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025....
Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, announced a strategic collaboration with...
New Pipeline Graph unifies competitive insights with preclinical research on a single AI platform to accelerate drug target identification and increase commercial success
Causaly announced Pipeline...